García-González Adolfo, Lotz Martin, Ochoa Jose L
Internal Medicine Service, Instituto Mexicano del Seguro Social (HGZMF 1), La Paz, B.C.S.
Rev Invest Clin. 2009 May-Jun;61(3):212-20.
Rheumatoid arthritis is an autoimmune inflammatory disease of unknown etiology, free radicals have been implicated in the genesis and perpetuation of damage in this pathology.
To evaluate the anti-inflammatory effect of Cu,Zn-superoxide dismutase (SOD) obtained from two different sources (bovine erythrocytes, Be-SOD, and Debaryomyces hansenii, Dh-SOD) with Type II Collagen-induced Arthritis model in rats.
Arthritis was induced by repeated injection of a porcine type II collagen-incomplete Freund adjuvant suspension on the back of Dark Augui (DA) rats. Arthritis was clinically evaluated throughout the study. Body weight was determined at three different times. Two different doses for each treatment (Be-SOD, Dh-SOD) were tested: 100 and 1,000 U/kg. At the end of the trial (day 28), histological analyses of the most inflamed ankle joint, as well as serum anti-collagen antibodies, were determined.
Both sources of SOD decreased, although to a different extent, the incidence and severity of the disease. Arthritis score was lower in all treatments, except for the low dose of Be-SOD. Groups receiving either source of SOD showed a significant weight increase compared to the placebo group. Histological damage was similar in all groups. Only the group that received the highest dose of Dh-SOD showed a significant lower antibody titer; nevertheless, no correlation appears to derive from arthritis score and antibody titer.
Our findings suggest that, although unable to counteract the arthritis syndrome, SOD may still be beneficial due to its anti-inflammatory activity. In the case of Dh-SOD, the best effect was observed at the highest dose tested.
类风湿性关节炎是一种病因不明的自身免疫性炎症疾病,自由基被认为与该病理过程中损伤的发生和持续存在有关。
在大鼠II型胶原诱导的关节炎模型中,评估从两种不同来源(牛红细胞,Be-SOD;汉逊德巴利酵母,Dh-SOD)获得的铜锌超氧化物歧化酶(SOD)的抗炎作用。
通过在暗奥吉(DA)大鼠背部反复注射猪II型胶原-不完全弗氏佐剂混悬液诱导关节炎。在整个研究过程中对关节炎进行临床评估。在三个不同时间点测定体重。对每种治疗(Be-SOD、Dh-SOD)测试两种不同剂量:100和1000 U/kg。在试验结束时(第28天),对最发炎的踝关节进行组织学分析,并测定血清抗胶原抗体。
两种来源的SOD均不同程度地降低了疾病的发生率和严重程度。除低剂量的Be-SOD外,所有治疗组的关节炎评分均较低。与安慰剂组相比接受任何一种SOD来源的组体重均显著增加。所有组的组织学损伤相似。仅接受最高剂量Dh-SOD的组抗体滴度显著降低;然而,关节炎评分与抗体滴度之间似乎没有相关性。
我们的研究结果表明,尽管SOD无法对抗关节炎综合征,但其抗炎活性可能仍然有益。就Dh-SOD而言,在测试的最高剂量下观察到最佳效果。